Salvage of infected cardiac implantable electronic device with taurolidine—a case report.
- Published in:
- Cardiothoracic Surgeon, 2022, v. 30, n. 1, p. 1, doi. 10.1186/s43057-022-00068-5
- By:
- Publication type:
- Article
Works by Baldauf, Benito
Results: 7
1
2
Misuse of Guidelines Could Disadvantage and Harm Patients.
- Published in:
- Journal of Evidence-Based Medicine, 2024, v. 17, n. 4, p. 705, doi. 10.1111/jebm.12666
- By:
- Publication type:
- Article
3
An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator.
- Published in:
- BMC Cardiovascular Disorders, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12872-024-04038-z
- By:
- Publication type:
- Article
4
Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection.
- Published in:
- EP: Europace, 2023, v. 25, n. 10, p. 1, doi. 10.1093/europace/euad306
- By:
- Publication type:
- Article
5
Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace™ registry.
- Published in:
- Journal of Cardiothoracic Surgery, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13019-024-03059-1
- By:
- Publication type:
- Article
6
The European TauroPace™ Registry.
- Published in:
- Methods & Protocols, 2023, v. 6, n. 5, p. 86, doi. 10.3390/mps6050086
- By:
- Publication type:
- Article
7
Prevalence of cardiac implantable electronic device infections in Germany in 2015.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82622-1
- By:
- Publication type:
- Article